Voxelotor for Sickle Cell Anemia Now Down to 4-Year-Olds

The indication has been extended down to children aged 4 years, and the FDA also approved a child-friendly, grape-flavored formulation.

Related Keywords

Voxelotor Oxbryta , ,Ted Love ,Global Blood Therapeutics ,Sickle Cell ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Hematology ,Physician Assistants ,Abdominal Pain ,Anemia ,Fever ,Us Food And Drug Administration ,Nited States Food And Drug Administration ,Fda ,Hemoglobin ,Emoglobin Hb ,Emoglobin Hgb ,Hemolytic Anemia ,Hyperthermia ,Heat Exhaustion ,Heat Prostration ,Pain Management ,